Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    12480423 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma
Conditions: Severe Persistent Asthma;   Eosinophilic Bronchitis
Interventions: Biological: Reslizumab;   Drug: Placebo
2 Unknown  The Clinical Profile of UK Asthma Patients With Raised Blood Eosinophils
Condition: Asthma
Intervention:
3 Completed LOMA: Long-Term Management of Asthma
Condition: Asthma
Interventions: Procedure: Induced sputum cell counts;   Drug: inhaled corticosteroids and other asthma drugs

Indicates status has not been verified in more than two years